These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37462820)

  • 1. Diffusion-weighted imaging complements T2-weighted MRI for tumour response assessment in squamous anal carcinoma.
    Prezzi D; Muthuswamy K; Amlani A; Owczarczyk K; Elowaidy A; Mistry T; Bassett P; Goh V
    Eur Radiol; 2023 Nov; 33(11):7575-7584. PubMed ID: 37462820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy and Clinical Impact of Persistent Disease Diagnosed on Diffusion-Weighted Imaging and Accuracy of Pelvic Nodal Assessment on Magnetic Resonance Imaging for Squamous Cell Carcinoma of the Anus in the 6-Month Interval Post Chemoradiotherapy.
    Fernandes MC; Charbel C; Romesser PB; Ucpinar BA; Homsi ME; Yildirim O; Fuqua JL; Rodriguez LA; Zheng J; Capanu M; Gollub MJ; Horvat N
    Int J Radiat Oncol Biol Phys; 2024 Sep; 120(1):120-129. PubMed ID: 38462017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The assessment of local response using magnetic resonance imaging at 3- and 6-month post chemoradiotherapy in patients with anal cancer.
    Kochhar R; Renehan AG; Mullan D; Chakrabarty B; Saunders MP; Carrington BM
    Eur Radiol; 2017 Feb; 27(2):607-617. PubMed ID: 27090113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of MRI sequence on tumour staging and gross tumour volume delineation in squamous cell carcinoma of the anal canal.
    Prezzi D; Mandegaran R; Gourtsoyianni S; Owczarczyk K; Gaya A; Glynne-Jones R; Goh V
    Eur Radiol; 2018 Apr; 28(4):1512-1519. PubMed ID: 29134349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion weighted imaging improves diagnostic ability of MRI for determining complete response to neoadjuvant therapy in locally advanced rectal cancer.
    Chandramohan A; Siddiqi UM; Mittal R; Eapen A; Jesudason MR; Ram TS; Singh A; Masih D
    Eur J Radiol Open; 2020; 7():100223. PubMed ID: 32140502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gross tumour volume delineation in anal cancer on T2-weighted and diffusion-weighted MRI - Reproducibility between radiologists and radiation oncologists and impact of reader experience level and DWI image quality.
    Min LA; Vacher YJL; Dewit L; Donker M; Sofia C; van Triest B; Bos P; van Griethuysen JJW; Maas M; Beets-Tan RGH; Lambregts DMJ
    Radiother Oncol; 2020 Sep; 150():81-88. PubMed ID: 32540336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Prospective Study of Diffusion-weighted Magnetic Resonance Imaging as an Early Prognostic Biomarker in Chemoradiotherapy in Squamous Cell Carcinomas of the Anus.
    Muirhead R; Bulte D; Cooke R; Chu KY; Durrant L; Goh V; Jacobs C; Ng SM; Strauss VY; Virdee PS; Qi C; Hawkins MA
    Clin Oncol (R Coll Radiol); 2020 Dec; 32(12):874-883. PubMed ID: 33023818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic Resonance Assessment of Peritoneal Carcinomatosis: Is There a True Benefit From Diffusion-Weighted Imaging?
    Cianci R; Delli Pizzi A; Patriarca G; Massari R; Basilico R; Gabrielli D; Filippone A
    Curr Probl Diagn Radiol; 2020; 49(6):392-397. PubMed ID: 31248709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of magnetic resonance imaging and 3D endoanal ultrasound in detection, staging and assessment post treatment, in anal cancer.
    Reginelli A; Granata V; Fusco R; Granata F; Rega D; Roberto L; Pellino G; Rotondo A; Selvaggi F; Izzo F; Petrillo A; Grassi R
    Oncotarget; 2017 Apr; 8(14):22980-22990. PubMed ID: 28152518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI heterogeneity analysis for prediction of recurrence and disease free survival in anal cancer.
    Owczarczyk K; Prezzi D; Cascino M; Kozarski R; Gaya A; Siddique M; Cook GJ; Glynne-Jones R; Goh V
    Radiother Oncol; 2019 May; 134():119-126. PubMed ID: 31005205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of Quantitative T2-Mapping Compared to Conventional and Advanced Diffusion Weighted Imaging Techniques for Multiparametric Prostate MRI in Men with Hip Prosthesis.
    Sathiadoss P; Schieda N; Haroon M; Osman H; Alrasheed S; Flood TA; Melkus G
    J Magn Reson Imaging; 2022 Jan; 55(1):265-274. PubMed ID: 34223675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of response to chemoradiation therapy in rectal cancer using MR volumetry based on diffusion-weighted data sets: a preliminary report.
    Carbone SF; Pirtoli L; Ricci V; Venezia D; Carfagno T; Lazzi S; Mourmouras V; Lorenzi B; Volterrani L
    Radiol Med; 2012 Oct; 117(7):1112-24. PubMed ID: 22580810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI and diffusion-weighted MRI to diagnose a local tumour regrowth during long-term follow-up of rectal cancer patients treated with organ preservation after chemoradiotherapy.
    Lambregts DM; Lahaye MJ; Heijnen LA; Martens MH; Maas M; Beets GL; Beets-Tan RG
    Eur Radiol; 2016 Jul; 26(7):2118-25. PubMed ID: 26518582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diffusion-weighted magnetic resonance imaging (DWI) predicts the early response of esophageal squamous cell carcinoma to concurrent chemoradiotherapy.
    Wang L; Liu L; Han C; Liu S; Tian H; Li Z; Ren X; Shi G; Wang Q; Wang G
    Radiother Oncol; 2016 Nov; 121(2):246-251. PubMed ID: 27838148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Image Quality Assessment of 2D
    Hausmann D; Liu J; Budjan J; Reichert M; Ong M; Meyer M; Smakic A; Grimm R; Strecker R; Schoenberg SO; Wang X; Attenberger UI
    Anticancer Res; 2018 Feb; 38(2):969-978. PubMed ID: 29374729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined PET-CT and MRI for response evaluation in patients with squamous cell anal carcinoma treated with curative-intent chemoradiotherapy.
    Adusumilli P; Elsayed N; Theophanous S; Samuel R; Cooper R; Casanova N; Tolan DJ; Gilbert A; Scarsbrook AF
    Eur Radiol; 2022 Aug; 32(8):5086-5096. PubMed ID: 35274187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI of anal cancer: assessing response to definitive chemoradiotherapy.
    Gourtsoyianni S; Goh V
    Abdom Imaging; 2014 Feb; 39(1):2-17. PubMed ID: 24072381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of state-of-the-art rectal MRI sequences for the diagnosis of extramural vascular invasion in locally advanced rectal cancer after preoperative chemoradiotherapy: dos or maybes?
    Crimì F; Angelone R; Corso A; Bao QR; Cabrelle G; Vernuccio F; Spolverato G; Pucciarelli S; Quaia E
    Eur Radiol; 2023 Oct; 33(10):6852-6860. PubMed ID: 37115215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric 3T MRI for the prediction of pathological downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3 + 4 prostate cancer.
    Gondo T; Hricak H; Sala E; Zheng J; Moskowitz CS; Bernstein M; Eastham JA; Vargas HA
    Eur Radiol; 2014 Dec; 24(12):3161-70. PubMed ID: 25100337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inter-reader agreement of multi-parametric MR imaging for the detection of prostate cancer: evaluation of a scoring system.
    Quentin M; Arsov C; Röhlen S; Klasen J; Antoch G; Albers P; Blondin D
    Rofo; 2012 Oct; 184(10):925-9. PubMed ID: 22744328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.